• Main page
• About the journal
• Editorial board
• Subscription
• Information for contributors
• Editorial and Peer Review
• Issues archive
• Authors
• Articles
  • By alphabet
  • By category
• Blogs and comments

The journal is included into The list of leading scientific periodicals.

The journal is included into VINITI database and is registered in Electronic scientific library.

The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2023.18004

Comparison of the effectiveness of non-selective β-blockers and endoscopic band ligation of esophageal varices in the primary prevention of bleeding in ascites patients from the waiting list for liver transplantation

[Original research] [Internal diseases]
Vyacheslav Leonidovich Korobka; Viktor Dmitrievich Pasechnikov; Roman Vyacheslavovich Korobka; Ekaterina S. Pak; Alexander Mikhailovich Shapovalov; Dmitry Viktorovich Pasechnikov; Igor Shitikov;

A retrospective comparative study of the effectiveness of non-selective β-blockers (n=104) and endoscopic ligation of varicose veins (n=82) in the primary prevention of esophageal bleeding and an assessment of the effect of these methods on the survival of patients with severe forms of ascites and varicose veins who had no episodes of bleeding before inclusion in the waiting list for liver transplantation. There were no significant between-group differences in clinical, laboratory, and demographic parameters, MELD scores, and Child-Turcotte-Pugh cirrhosis grades, rates of medium to large varices, and rates of severe ascites. There were no significant differences in the incidence of bleeding in the compared groups. Survival of patients in the compared groups did not have a significant difference

Download

References:
1. D’Amico G., Bernardi M., Angeli P. Towards a new definition of decompensated cirrhosis. J. Hepatol. 2022;76(1):202-207. https://doi.org/10.1016/j.jhep.2021.06.018
2. D’Amico G., Perricone G. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter? Curr. Hepatology Rep. 2019;18:144-156. https://doi.org/10.1007/s11901-019-00473-1
3. D’Amico G., Villanueva C., Burroughs A. K., Dollinger M. M., Planas R. [et al.]. Clinical stages of cirrhosis a multicenter study of 1858 patients. Hepatology. 2010;52(S1):329A.
4. D’Amico G., Pasta L., Morabito A., D’Amico M., Caltagirone M. [et al.]. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment. Pharmacol. Ther. 2014;39(10):1180-1193. https://doi.org/10.1111/apt.12721
5. De Franchis R., Bosch J., Garcia-Tsao G., Reiberger T., Ripoll C. Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. J. Hepatol. 2022;76(4):959-974. https://doi.org/10.1016/j.jhep.2021.12.022
6. Kwong A. J., Ebel N. H., Kim W. R., Lake J. R., Smith J. M. [et al.]. OPTN/SRTR 2020 Annual Data Report: Liver. Am. J. Transplant. 2022;22(Suppl. 2):204-309. https://doi.org/10.1111/ajt.16978
7. Toniutto P., Zanetto A., Ferrarese A., Burra P. Current challenges and future directions for liver transplantation. Liver Int. 2017;37(3):317-327. https://doi.org/10.1111/liv.13255
8. Gautier S. V., Khomyakov S. M. Organ donation and transplantation in the Russian Federation in 2021. 14th Report from the Registry of the Russian Transplant Society. Russ. J. Transplantol. Artific. Org. 2022;24(3):8-31. https://doi.org/10.15825/1995-1191-2022-3-8-31
9. Korobka V. L., Pasechnikov V. D., Korobka R. V., Pak E. S., Shapovalov A. M. Use of endoscopic band ligation alone and in combination with nonselective beta blockers for prevention of variceal bleeding in ascites patients on the liver transplant waiting list. Vestnik transplantologii i iskusstvennykh organov. – Russ. J. Transplantol. Artific. Org. 2022;24(3):42-50. (In Russ.). https://doi.org/10.15825/1995-1191-2022-3-42-50
10. Leise M. D., Kim W. R., Kremers W. K., Larson J. J., Larson J. J. [et al.]. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011;140:1952-1960. https://doi.org/10.1053/j.gastro.2011.02.017
11. Child C. G., Turcotte J. G. Surgery and portal hypertension. Major Probl. Clin. Surg. 1964;1:1-85.
12. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973;60(8):646-649. https://doi.org/10.1002/bjs.1800600817
13. De Franchis R., Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J. Hepatol. 2015;63:743-752. https://doi.org/10.1016/j.jhep.2015.05.022
14. Varicose veins of the esophagus. Practical recommendations of the World Gastroenterological Organization. Available at: https://www.worldgastroenterology.org/UserFiles/file/guidelines/esophageal-varices-russian-2014.pdf
15. Moore K. P., Wong F., Gines P., Bernardi M., Ochs A. [et al.]. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38(1):258-266. https://doi.org/10.1053/jhep.2003.50315
16. D’Amico G., Morabito A., D’Amico M., Pasta L., Malizia G. [et al.]. Clinical states of cirrhosis and competing risks. J. Hepatol. 2018;68(3):563-576. https://doi.org/10.1016/j.jhep.2017.10.020
17. Téllez L., Albillos A. Non-selective beta-blockers in patients with ascites: The complex interplay among the liver, kidney and heart. Liver Int. 2022;42(4):749-761. https://doi.org/10.1111/liv.15166
18. Pérez-Ayuso R. M., Valderrama S., Espinoza M., Rollán A., Sánchez R. [et al.]. Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices. Ann. Hepatol. 2010;9(1):15-22.
19. Wei Z. G., Wei F. X., Shao Z. W., Su G. H., Qi X. P., Zhang Y. C. Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension. Ther. Clin. Risk Manag. 2018;15:45-57. https://doi.org/10.2147/TCRM.S184863
20. Pfisterer N., Dexheimer C., Fuchs E. M., Bucsics T., Schwabl P. [et al.]. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment. Pharmacol. Ther. 2018;47(7):966-979. https://doi.org/10.1111/apt.14485
21. Tripathi D., Ferguson J. W., Kochar N., Leithead J. A., Therapondos G. [et al.]. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology. 2009;50(3):825-833. https://doi.org/10.1002/hep.23045
22. Reiberger T., Ulbrich G., Ferlitsch A., Payer B. A., Schwabl P.[et al.]. Vienna Hepatic Hemodynamic Lab. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 2013;62(11):1634-1641. https://doi.org/10.1136/gutjnl-2012-304038
23. Turco L., Villanueva C., La Mura V., García-Pagán J. C., Reiberger T. [et al.]. Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis. Clin. Gastroenterol. Hepatol.2020;18(2):313-327.e6. https://doi.org/10.1016/j.cgh.2019.05.050
24. Paternostro R., Becker J., Hofer B. S., Panagl V., Schiffke H. [et al.]. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices. Dig. Liver Dis. 2022;54(4):500-508. https://doi.org/10.1016/j.dld.2021.09.009
25. Reiberger T., Schwabl P., Trauner M., Peck-Radosavljevic M., Mandorfer M. Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy. J. Vis. Exp. 2020;(160). https://doi.org/10.3791/58819
26. Hernández-Gea V., Aracil C., Colomo A., Garupera I., Poca M. [et al.]. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers. Am. J. Gastroenterol. 2012;107(3):418-427. https://doi.org/10.1038/ajg.2011.456
27. D’Amico G., Garcia-Pagan J. C., Luca A., Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131(5):1611-1624. https://doi.org/10.1053/j.gastro.2006.09.013
28. Villanueva C., Aracil C., Colomo A., Hernández-Gea V., López-Balaguer J. M. [et al.]. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology. 2009;137(1):119-128. https://doi.org/10.1053/j.gastro.2009.03.048
29. Hofer B. S., Simbrunner B, Bauer D. J. M., Paternostro R., Schwabl P. [et al.]. Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis. Hepatol. Commun. 2022;6(9):2569-2580. https://doi.org/10.1002/hep4.2021

Keywords: waiting list for liver transplantation, ascites, bleeding, survival, non-selective β-blockers, endoscopic band ligation